Quick News Bit

MDMA Cured Extremism? Abilify Pain Cream Scheme; Ritalin’s Opposite Effect in Some

0

After the former leader of a white nationalist group took a single dose of MDMA during a psychiatric clinical study, he revised his extremist views. (BBC)

Is laughter the best medicine? A meta-analysis of 29 studies found that “humor therapy” helped relieve depression and anxiety. (Brain and Behavior)

Two Jacksonville, Florida-based compounding pharmacies agreed to pay at least $7.4 million to settle lawsuits after they violated the False Claims Act by adding aripiprazole (Abilify) to topical compounded pain creams to boost reimbursement, according to the Department of Justice.

A state-level analysis showed that men died from opioid or stimulant overdoses at more than twice the rate of women in the U.S. (Neuropsychopharmacology)

How has Taylor Swift changed this one psychiatrist’s office? (New York Times)

Cognitive behavioral therapy improved insomnia and alcohol-related problems compared with sleep hygiene alone and “should be considered a first-line treatment for insomnia, regardless of abstinence,” said researchers in JAMA Psychiatry.

For people without attention deficit-hyperactivity disorder, taking commonly prescribed stimulants like methylphenidate (Ritalin) may actually decrease productivity. (Science Advances)

The first person ever diagnosed with autism, Donald Triplett, has died at age 89. (AP)

The site of a defunct psychiatric hospital in Queens, New York, is being eyed for 3,000 new units of affordable housing. (Gothamist)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.

For all the latest Health News Click Here 

 For the latest news and updates, follow us on Google News

Read original article here

Denial of responsibility! NewsBit.us is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.

Leave a comment